Publicacions en què col·labora amb Joan Montaner Villalonga (7)

2023

  1. Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial

    JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788

2022

  1. Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance

    Neurologia, Vol. 37, Núm. 2, pp. 136-150

2017

  1. GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke

    Stroke, Vol. 48, Núm. 5, pp. 1147-1153

2016

  1. Combination of thrombolysis and statins in acute stroke is safe: Results of the STARS randomized trial (Stroke Treatment With Acute Reperfusion and Simvastatin)

    Stroke, Vol. 47, Núm. 11, pp. 2870-2873

2015

  1. CholesteroNitrones for Stroke

    Journal of Medicinal Chemistry, Vol. 58, Núm. 16, pp. 6704-6709

2011

  1. No evidence of APP point mutation and locus duplication in individuals with cerebral amyloid angiopathy

    European Journal of Neurology, Vol. 18, Núm. 10, pp. 1279-1281

2010

  1. Stroke with polyvascular atherothrombotic disease

    Atherosclerosis, Vol. 208, Núm. 2, pp. 587-592